Abstract
Cortistatin A is a natural product isolated from the marine sponge Corticium simplex and was found to be a potent and selective inhibitor of CDK8. Many synthetic groups have reported total syntheses of Cortistatin A; however, these syntheses require between 16 and 30 steps and report between 0.012-2% overall yields, which is not amenable to large-scale production. Owing to similarities between the complex core of Cortistatin A and the simple steroid core, we initiated a campaign to design simple, more easily prepared CDK8 inhibitors based on a steroid scaffold that would be more convenient for large-scale synthesis. Herein, we report the discovery and optimization of JH-VIII-49, a potent and selective inhibitor of CDK8 with a simple steroid core that has an eight-step synthesis with a 33% overall yield, making it suitable for large-scale preparation. Using this scaffold, we then developed a bivalent small molecule degrader, JH-XI-10-02, that can recruit the E3 ligase CRL4Cereblon to promote the ubiquitination and proteosomal degradation of CDK8.
Original language | English |
---|---|
Pages (from-to) | 540-545 |
Number of pages | 6 |
Journal | ACS Medicinal Chemistry Letters |
Volume | 9 |
Issue number | 6 |
DOIs | |
Publication status | Published - 2018 Jun 14 |
Bibliographical note
Publisher Copyright:© Copyright 2018 American Chemical Society.
Keywords
- CDK19
- CDK8
- Cereblon
- Cortistatin A
- E3 ligase
- PROTAC
- degradation
- kinase inhibitor
- mediator complex
ASJC Scopus subject areas
- Biochemistry
- Drug Discovery
- Organic Chemistry